Patent · US Expired

Imidazoquinoline antithrombrogenic cardiotonic agents

US4668686A · kind A · utility

31Cited by
0References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 1986
Grant dateMay 26, 1987
Priority date
Expiry dateFeb 26, 2006

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel series of 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones of the Formula ##STR1## wherein R.sub.1 is halogen, lower alkyl, lower alkoxy, trifluoromethyl; R.sub.2 is hydrogen, halogen, lower alkyl, lower alkoxy; R.sub.3 is hydrogen, halogen, lower alkyl, lower alkoxy; and R.sub.4 is hydrogen or lower alkyl. The compounds are therapeutically useful as inhibitors of blood platelet aggregation and/or as cardiotonic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.